The success of a new dental implant in the jaw bone
- Conditions
- Single or multiple teeth missing in both jawsOral Health
- Registration Number
- ISRCTN15663606
- Lead Sponsor
- Straumann (Switzerland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 80
1. Aged 18 years old and over
2. Requiring a single or partial fixed implant prosthesis (FDP) of maxillary and mandibular arch
3. Otherwise healthy patients
4. Full mouth bleeding and full mouth plaque index lower than or equal to 25%
5. Bone height for at least 4 mm-long implants
6. Bone width of at least 3 mm and 4 mm
7. Fresh extraction sockets with an intact buccal wall
1. Psychiatric contraindications
2. Pregnancy or nursing
3. Any interfering medication such as:
3.1. Steroid therapy
3.2. Bisphosphonate therapy
4. Alcohol or drug abuse
5. Heavy smoking (>10 cigarettes/day)
6. Radiation therapy to head or neck region within 5 years
7. Untreated periodontitis
8. Acute and chronic infections of the adjacent tissues or natural dentition
9. Severe maxillomandibular skeletal discrepancy
10. High and moderate parafunctional activity
11. Absence of opposite teeth
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Implantation survival rate (ISR) measured during a control visit every 4 months. A surviving implant is an implant that maintains its function in the mouth.<br> 2. Marginal bone loss (MBL) measured using annual periapical X-rays<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Initial implant stability quotient values (ISQ-0) and insertion torque at implant placement recorded at each scheduled visit every 4 months from implant placement<br> 2. Peri-implant soft tissue parameters recorded at each scheduled visit every 4 months from implant placement:<br> 2.1. Bleeding on probing (BoP) measured using a periodontal probe<br> 2.2. Probing depth (PD) measured using a periodontal probe<br> 2.3. Implant stability measured using ISQ values from a resonance frequencies analysis using the Osstel device<br>